current position:Home >> News

A basket trial of arsenic trioxide in treating p53-mutated tumors was initialized by Jun Zhang,

the director of oncology department, and Min Lu in Ruijin Hospital （ClinicalTrials.gov: NCT04869475）

Previous:Mutant p53 rescue compound is scheduled for clinical trials in National Translational Center of Next:The finding of reactivation of structural p53 mutants by Arsenic Trioxide was previewed by